Drug name - Hysingla Er

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9675610 PURDUE PHARMA LP Abuse-proofed dosage form Jun, 2023

(8 months from now)

US10369109 PURDUE PHARMA LP Abuse-proofed dosage form Jun, 2023

(8 months from now)

US8309060 PURDUE PHARMA LP Abuse-proofed dosage form Nov, 2023

(1 year, 1 month from now)

US10130591 PURDUE PHARMA LP Abuse-proofed dosage form Nov, 2023

(1 year, 1 month from now)

US9763933 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9095615 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9492389 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9095614 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9545380 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9492391 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9492390 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9770416 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9486413 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9084816 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9486412 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9775809 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9861584 PURDUE PHARMA LP Tamper resistant controlled release dosage forms Dec, 2031

(9 years from now)

US9872837 PURDUE PHARMA LP Tamper resistant controlled release dosage forms Dec, 2031

(9 years from now)

US9572779 PURDUE PHARMA LP Encased tamper resistant controlled release dosage forms Dec, 2031

(9 years from now)

US9750703 PURDUE PHARMA LP Encased tamper resistant controlled release dosage forms Dec, 2031

(9 years from now)

US8808740 PURDUE PHARMA LP Encased tamper resistant controlled release dosage forms Dec, 2031

(9 years from now)

Drugs and Companies using HYDROCODONE BITARTRATE ingredient

Treatment: Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate; Management of pain severe enough to require daily, around-the-clock, long term opioid treatment and for which alternative treatment options are inadequate

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
20MG TABLET, EXTENDED RELEASE;ORAL Prescription
30MG TABLET, EXTENDED RELEASE;ORAL Prescription
40MG TABLET, EXTENDED RELEASE;ORAL Prescription
60MG TABLET, EXTENDED RELEASE;ORAL Prescription
80MG TABLET, EXTENDED RELEASE;ORAL Prescription
100MG TABLET, EXTENDED RELEASE;ORAL Prescription
120MG TABLET, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.